Related references
Note: Only part of the references are listed.An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline (vol 64, e01650-20, 2020)
Steven J. Kovacs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Pharmacokinetics and Safety of Single-Dose Amphotericin B Colloidal Dispersion in Healthy Chinese Subjects and Population Pharmacokinetic/Pharmacodynamic Analysis to Inform Clinical Efficacy in Invasive Infections Caused by Candida albicans
Zhi-Wei Huang et al.
CLINICAL THERAPEUTICS (2021)
In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii
A. R. Noel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data
Elizabeth A. Lakota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018
Dong Dong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline
Steven J. Kovacs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study
Meng Xiao et al.
BMC MICROBIOLOGY (2020)
Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study
J. Scott Overcash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
William O'Riordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Omadacycline for Community-Acquired Bacterial Pneumonia
Roman Stets et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
Chia-Chi Lin et al.
BRITISH JOURNAL OF CANCER (2019)
Microbiology and Preclinical Review of Omadacycline
James A. Karlowsky et al.
CLINICAL INFECTIOUS DISEASES (2019)
Omadacycline for Acute Bacterial Skin and Skin Structure Infections
Fredrick M. Abrahamian et al.
CLINICAL INFECTIOUS DISEASES (2019)
Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)
Cecilia G. Carvalhaes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
Jolene K. Berg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens
Lu Ann Bundrant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of C-14-Omadacycline in Rats
Wen Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Effect of Food on the Bioavailability of Omadacycline in Healthy Participants
Evan Tzanis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
Mark H. Gotfried et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects
Haiying Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
Michael P. Draper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Share Paper
